Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Furst

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Annals of the Rheumatic Diseases|February 2, 2012
A comparative effectiveness study of adalimumab, etanercept and infliximab in biologically naive and switched rheumatoid arthritis patients: results from the US CORRONA registryJeffrey D Greenberg, George Reed, Dennis Decktor, et al.
The Journal of Rheumatology|January 12, 2007
Patient self-administered joint tenderness counts in rheumatoid arthritis are reliable and responsive to changes in disease activityFernando Figueroa, Yolanda Braun-Moscovici, Dinesh Khanna, et al.
Annals of the Rheumatic Diseases|March 20, 2014
Efficacy and safety of olokizumab in patients with rheumatoid arthritis with an inadequate response to TNF inhibitor therapy: outcomes of a randomised Phase IIb studyMark C Genovese, Roy Fleischmann, Daniel Furst, et al.
Annals of the American Thoracic Society|September 29, 2018
Longitudinal Changes in Quantitative Interstitial Lung Disease on Computed Tomography after Immunosuppression in the Scleroderma Lung Study IIJonathan G Goldin, Grace Hyun J Kim, Chi-Hong Tseng, et al.
The Journal of Rheumatology|May 5, 2007
Systemic sclerosis - continuing progress in developing clinical measures of responseDaniel Furst, Dinesh Khanna, Marco Matucci-Cerinic, et al.
Annals of the Rheumatic Diseases|December 3, 2014
Relationship between quantitative radiographic assessments of interstitial lung disease and physiological and clinical features of systemic sclerosisDonald P Tashkin, Elizabeth R Volkmann, Chi-Hong Tseng, et al.
BMJ Open|September 7, 2021
Risk of harm in synthetic and biological intervention trials in patients with inflammatory arthritis: protocol for a metaepidemiological study focusing on contextual factorsEsben Malm, Sabrina Mai Nielsen, Johannes Berg, et al.
Physiology & Behavior|May 10, 2023
Screening study of anti-emetics to improve GDF15-induced malaise and anorexia: Implications for emesis controlTito Borner, Sarah A Doebley, C Daniel Furst, et al.
Molecular Metabolism|May 28, 2023
GIP receptor agonism blocks chemotherapy-induced nausea and vomitingTito Borner, Benjamin C Reiner, Richard C Crist, et al.
Journal of Scleroderma and Related Disorders|April 7, 2022
The role of ultrasound in systemic sclerosis: On the cutting edge to foster clinical and research advancementMichael Hughes, Cosimo Bruni, Giovanna Cuomo, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Annals of the Rheumatic Diseases|February 2, 2012
A comparative effectiveness study of adalimumab, etanercept and infliximab in biologically naive and switched rheumatoid arthritis patients: results from the US CORRONA registryJeffrey D Greenberg, George Reed, Dennis Decktor, et al.
The Journal of Rheumatology|January 12, 2007
Patient self-administered joint tenderness counts in rheumatoid arthritis are reliable and responsive to changes in disease activityFernando Figueroa, Yolanda Braun-Moscovici, Dinesh Khanna, et al.
Annals of the Rheumatic Diseases|March 20, 2014
Efficacy and safety of olokizumab in patients with rheumatoid arthritis with an inadequate response to TNF inhibitor therapy: outcomes of a randomised Phase IIb studyMark C Genovese, Roy Fleischmann, Daniel Furst, et al.
Annals of the American Thoracic Society|September 29, 2018
Longitudinal Changes in Quantitative Interstitial Lung Disease on Computed Tomography after Immunosuppression in the Scleroderma Lung Study IIJonathan G Goldin, Grace Hyun J Kim, Chi-Hong Tseng, et al.
The Journal of Rheumatology|May 5, 2007
Systemic sclerosis - continuing progress in developing clinical measures of responseDaniel Furst, Dinesh Khanna, Marco Matucci-Cerinic, et al.
Annals of the Rheumatic Diseases|December 3, 2014
Relationship between quantitative radiographic assessments of interstitial lung disease and physiological and clinical features of systemic sclerosisDonald P Tashkin, Elizabeth R Volkmann, Chi-Hong Tseng, et al.
BMJ Open|September 7, 2021
Risk of harm in synthetic and biological intervention trials in patients with inflammatory arthritis: protocol for a metaepidemiological study focusing on contextual factorsEsben Malm, Sabrina Mai Nielsen, Johannes Berg, et al.
Physiology & Behavior|May 10, 2023
Screening study of anti-emetics to improve GDF15-induced malaise and anorexia: Implications for emesis controlTito Borner, Sarah A Doebley, C Daniel Furst, et al.
Molecular Metabolism|May 28, 2023
GIP receptor agonism blocks chemotherapy-induced nausea and vomitingTito Borner, Benjamin C Reiner, Richard C Crist, et al.
Journal of Scleroderma and Related Disorders|April 7, 2022
The role of ultrasound in systemic sclerosis: On the cutting edge to foster clinical and research advancementMichael Hughes, Cosimo Bruni, Giovanna Cuomo, et al.
Pageof 4